| Identification | |
| Name: | 1A,25-dihydroxycholecalciferol |
| CAS: | 32222-06-3 |
| EINECS: | 250-963-8 |
| Molecular Formula: | C27H44O3 |
| Molecular Weight: | 416.64 |
| InChI: | InChI=1/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22+,23+,24?,25?,27+/m0/s1 |
| Molecular Structure: |  |
| Properties | |
| Transport: | UN 2811 |
| Density: | 1.06g/cm3 |
| Stability: | No data. |
| Refractive index: | 1.547 |
| Solubility: | Insoluble |
| Appearance: | White Crystalline Powder |
| Specification: |
?1alpha,25-Dihydroxycholecalciferol , with CAS number of 32222-06-3, can be called (5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1-alpha,3-beta,25-triol ; (5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta,25-triol ; 1,25-Dihydroxyvitamin D ; 9,10-Seco(5Z,7E)-5,7,10(19)-cholestatriene-1alpha,3beta,25-triol ; Vectical . It is a?white crystalline powder. 1alpha,25-Dihydroxycholecalciferol (CAS NO.32222-06-3) can be used as vitamin D3. Calcium regulator; vitamin (antirachitic); antihyperparathyroid; and antineoplastic. |
| Packinggroup: | I |
| Biological Activity: | Active metabolite of vitamin D 3 that activates the vitamin D receptor (VDR). Displays calcemic actions; stimulates intestinal and renal Ca 2+ absorption and regulates bone Ca 2+ turnover. Exhibits antitumor activity; inhibits in vivo and in vitro cell proliferation in a wide range of cells including breast, prostate, colon, skin and brain carcinomas and myeloid leukemia cells. |
| Color: | Colorless, crystalline solid White crystalline powder |
| Usage: | The biologically active form of vitamin D3. Calcium regulator; vitamin (antirachitic); antihyperparathyroid; antineoplastic; antipsoriatic |
| Safety Data | |
| Hazard Symbols |
T+:Verytoxic
|
 |
|
